Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Perrigo Company plc    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Perrigo : 'Quitting is better' Campaign Enters its Fourth Year of Partnership with the American Cancer Society

11/20/2020 | 08:48am EST

Allegan - Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, is pleased to announce the fourth year of its 'Quitting is Better' campaign in partnership with the American Cancer Society (ACS).

Since 2017, Perrigo has supported the American Cancer Society's efforts to provide tools and resources for people seeking information, help, and guidance to quit smoking. The ACS is committed to attacking cancer from every angle, which includes helping people quit smoking. Tobacco use is the leading preventable cause of cancer and cancer deaths in the United States.

This year's exclusive partnership for Perrigo's nicotine replacement therapy (NRT) smoking cessation products promises to be the most successful campaign to date with a first-of-its-kind store brand category promotion available to all of the Company's customers. As part of the campaign partnership, Perrigo is providing participating retailers with print and digital promotional materials, including on-pack messaging, shelf signage, store displays, store circular advertisements, and digital content to support online offers and loyalty programs.

The promotion aligns with today's ACS Great American Smokeout event, when thousands of people across the country who smoke take an important step toward a healthier life and reduced cancer risk. During this campaign, consumers can access the ACS's resources and support and purchase Perrigo's affordable store brand NRT products at participating retailers throughout the U.S. until the end of January.

'We are very pleased to enter our fourth year of partnership with the ACS. This partnership has been highly effective in driving awareness and incremental sales for store brand NRT products, while providing consumers with access to ACS's smoking database and research to help them get the resources they need to quit smoking,' commented Angela Gusse, Perrigo's Marketing Director for the Skincare & Personal Wellness and Healthy Lifestyles categories. 'Our NRT products advance our vision and self-care strategy while improving the health and wellness of consumers. We are excited to build on our successful partnership with the ACS and help even more people quit tobacco use.'

Howard Byck, Senior Vice President of Corporate and Sports Alliances at the American Cancer Society, remarked, 'We know that decreasing and ultimately eliminating tobacco usage also decreases the risk for lung and many other cancers and Perrigo's nicotine replacement products closely align with our mission to save lives.' Byck continued, 'For four years, Perrigo has partnered with the American Cancer Society through its 'Quitting is Better' Campaign, and we could not be more appreciative of their support.'

Perrigo's healthy lifestyle product portfolio comprises mainly smoking cessation and NRT products, including a full range of oral nicotine offerings to help smokers kick the habit or cut down on tobacco use. Smokers can choose from coated or uncoated gum and regular or mini lozenges. Flavors include Mint, Fruit, Citrus, Cherry and Cinnamon and come in 2 mg and 4 mg strengths. Perrigo NRT products can be found across the retail marketplace in many retail stores and online.

About Perrigo

Perrigo Company plc (NYSE; TASE: PRGO) is a leading provider of Quality, Affordable Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Led by its consumer self-care strategy, Perrigo is the largest store brand OTC player in the U.S. in the categories in which it competes through more than 9,000 SKUs under customer 'own brand' labels. Additionally, Perrigo is a Top 5 OTC company by revenue in Europe, where it markets more than 200 branded OTC products throughout 28 countries. The Company also commercializes and manufactures generic prescription products in the U.S.

Contact:

Lyndsey Chmiel

Tel: (269) 673-9324

Email: lyndsey.chmiel@perrigo.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about PERRIGO COMPANY PLC
01/07INSIDER TRENDS : Insider Purchase Prolongs Perrigo Company Positive Trend
MT
01/06PERRIGO : RBC Capital Downgrades Perrigo Company to Sector Perform From Outperfo..
MT
2020PERRIGO CO PLC : Change in Directors or Principal Officers (form 8-K)
AQ
2020PERRIGO COMPANY PLC : Ex-dividend day for
FA
2020PERRIGO : 'Quitting is better' Campaign Enters its Fourth Year of Partnership wi..
AQ
2020Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corpora..
AQ
2020INSIDER TRENDS : Insider Buying Added to with Purchase of Perrigo Company Stock
MT
2020PERRIGO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
2020PERRIGO : 3Q Earnings Snapshot
AQ
2020Perrigo Company Reports Q3 Adjusted EPS of $0.93, Reaffirms 2020 Outlook
MT
More news
Financials (USD)
Sales 2020 5 114 M - -
Net income 2020 65,6 M - -
Net Debt 2020 2 738 M - -
P/E ratio 2020 63,7x
Yield 2020 2,06%
Capitalization 5 909 M 5 909 M -
EV / Sales 2020 1,69x
EV / Sales 2021 1,57x
Nbr of Employees 11 200
Free-Float 99,2%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 52,89 $
Last Close Price 43,29 $
Spread / Highest target 47,8%
Spread / Average Target 22,2%
Spread / Lowest Target -7,60%
EPS Revisions
Managers and Directors
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Rolf Allan Classon Chairman
Raymond P. Silcock Chief Financial & Accounting Officer
Thomas Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC-3.20%5 909
JOHNSON & JOHNSON3.92%430 552
ROCHE HOLDING AG3.06%308 615
NOVARTIS AG2.73%220 726
MERCK & CO., INC.-1.00%204 882
PFIZER INC.-0.71%203 159